15.08.2013 • NewsAshlandASK ChemicalsClariant

Clariant, Ashland Put Foundry Chemical Venture Up For Sale

Swiss chemicals maker Clariant and U.S. peer Ashland are putting their German foundry chemicals venture up for auction as both companies restructure their operations, two people familiar with the plans told Reuters.

The sale of ASK Chemicals, which has about €25-30 million in annual core earnings and relies on volatile demand from steel and metal makers, comes as both Clariant and Ashland try to focus on products that are more profitable and less exposed to cyclical swings in the economy.

Ashland, owner of the Valvoline motor oil brand, said last month it might sell its water treatment unit. Activist investor Jana Partners pushed for the company to do more to boost value for shareholders.

Clariant, for its part, sold businesses including textile and paper chemicals to U.S. private equity firm SK Capital last year and is trying to divest its leather chemicals, detergents and intermediates units.

Hilden, Germany-based ASK, which has 1,800 staff, is under operational control of Clariant, even though the venture partners each hold a 50% equity stake. Its main rival is unlisted Huettenes-Albertus, also Germany-based.

The sources said Unicredit has been mandated to run the sale, which the owners hope will yield about 5-7 times annual earnings before interest, tax, depreciation and amortization (EBITDA). That would value the group at €125-210 million.

Information packs on ASK are to be sent out by late September, the sources said.

Rival Asian foundry chemical makers are seen as prospective buyers and Permira, among other buyout firms, will also take a look at the business, the sources said.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read